Chemical substance

SOCMA CONCLUDES 2024 SHOW, ATTENDEES SIGNAL OPTIMISM FOR THE YEAR AHEAD

Retrieved on: 
Thursday, February 22, 2024
Intelligence, Society, Directory, Capital expenditure, Chevron Corporation, Chemical substance, Nasi, Research, Speciality chemicals

The three-day event, held at the JW Marriott Nashville, boasted over 1050 attendees and 157 exhibitors, along with 36 company showcases.

Key Points: 
  • The three-day event, held at the JW Marriott Nashville, boasted over 1050 attendees and 157 exhibitors, along with 36 company showcases.
  • In her address to attendees, Jennifer Abril, President and CEO of SOCMA, highlighted new research and anecdotal evidence suggesting the industry stands on the cusp of a positive year.
  • As North American manufacturers, we have strong grounds to expect increased demand in the months and years ahead."
  • The SOCMA 2024 Show sponsors include: Chevron Oronite; Nation Ford Chemical; Anchin; Ascent Chemicals; Entegris; ChemDesign; International Process Plants; NASi; Toll Solutions.

Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies

Retrieved on: 
Tuesday, February 20, 2024
Lipid, Messenger, PEGylation, ANN, Catalog, COVID-19 vaccine, RNA, COVID-19, Chemical substance, Sterol, Research, Cancer, Sand

ANN ARBOR, Mich., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits. The LipidLaunch™ product line is the latest addition to the company's portfolio of LNP research tools and reflects the company's legacy of providing high-quality lipids for academic, pharma, and biotech researchers worldwide.

Key Points: 
  • Cayman Chemical introduces the latest addition to the company's portfolio of lipid nanoparticle (LNP) research tools for academic, pharma, and biotech researchers worldwide.
  • ANN ARBOR, Mich., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits.
  • The LipidLaunch™ product line is the latest addition to the company's portfolio of LNP research tools and reflects the company's legacy of providing high-quality lipids for academic, pharma, and biotech researchers worldwide.
  • Cayman's LipidLaunch™ products support LNP research and development from discovery to bioanalysis with a range of purpose-built solutions.

Global Solenoid Valves Strategic Industry Report 2024: Market to Reach $5.2 Billion by 2030 - Healthy Outlook for the World Chemical Industry Extends a Fillip to Solenoid Valves Demand - ResearchAndMarkets.com

Retrieved on: 
Friday, February 16, 2024
Chemicals, Plastics, Manufacturing, Wastewater, Food, Oil, Electricity generation, Chemical substance, Foodservice, Developed country

World Solenoid Valves Market by End-Use (2023 & 2030): Percentage Breakdown of Sales for Chemical & Petrochemical, Oil & Gas, Water & Wastewater, Power Generation, Food & Beverage, and Other End-Uses

Key Points: 
  • World Solenoid Valves Market by End-Use (2023 & 2030): Percentage Breakdown of Sales for Chemical & Petrochemical, Oil & Gas, Water & Wastewater, Power Generation, Food & Beverage, and Other End-Uses
    World Solenoid Valves Market - Geographic Regions Ranked by CAGR (Sales) for 2022-2030: China, Asia-Pacific, Latin America, Middle East, Africa, USA, Canada, Europe, and Japan
    Cornering a Large Percentage of New Refining Capacity Additions, Developing Regions & the USA Emerge as Lucrative Pockets of Growth for Solenoid Valves in the Oil Refining Sector
    Aira Euro Automation Pvt Ltd.
    Christian Burkert GmbH & Co. KG

SOCMA Announces Promotions and Additions to Staff

Retrieved on: 
Thursday, February 15, 2024
CFO, Engineering, Marketing, Health, Culture, Technical, Nate, ESG, Washington Metro, Government, Amber, Society, Organization, EHS, Chemical substance, Knowledge, Amazon, Speciality chemicals

ARLINGTON, Va. , Feb. 15, 2024 /PRNewswire/ -- The Society of Chemical Manufacturers & Affiliates, Inc (SOCMA) proudly announces the promotions of five members of its current team, as well as two new hires.

Key Points: 
  • ARLINGTON, Va. , Feb. 15, 2024 /PRNewswire/ -- The Society of Chemical Manufacturers & Affiliates, Inc (SOCMA) proudly announces the promotions of five members of its current team, as well as two new hires.
  • "It is my pleasure to announce these well-deserved promotions, and I am delighted to welcome our new additions.
  • As the leading association for the specialty batch chemical sector, SOCMA has a commitment to ensuring our staff bring relevant knowledge and experience that enhance business value for SOCMA members," said Jennifer Abril, SOCMA President & CEO.
  • Joe joined SOCMA in 2018 following a 16+ year career in EHS&S and Government Relations for a SOCMA member company.

Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design

Retrieved on: 
Thursday, February 15, 2024
DNA, Saponin, GMD, Toxicity, Enzyme, Ginkgo Bioworks, Medicine, SVP, Partnership, Animal, Vaccine, ADC, Refrigeration, Vaccination, Shingles, Malaria, COVID-19, Respiratory syncytial virus, Chemical substance, Saccharomyces cerevisiae, CBD, DTRA, Protein, MCDC, QS-21, Plague, Ginkgo

Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination.

Key Points: 
  • Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination.
  • Currently, only a handful of adjuvants are available for human use in licensed vaccines.
  • Ginkgo will develop a first-generation Adjuvant Development Candidate (ADC) production method, using a heterologous production strain such as brewers' yeast, Saccharomyces cerevisiae.
  • Development of a first-generation ADC production method could facilitate further development of a sustainable mass-production manufacturing process for these complex adjuvants.

Canaery-led Research Team Funded by US National Science Foundation Convergence Accelerator

Retrieved on: 
Tuesday, February 13, 2024
Defense, Nanotechnology, Other Science, State, Local, Other Technology, Research, Other Defense, Software, Artificial Intelligence, Hardware, Homeland Security, Science, Technology, Public Policy, Government, Neurology, Law Enforcement, Emergency Services, Health, Apps, Applications, Fentanyl, Smell, Doctor of Philosophy, NCI, Multimedia, Artificial intelligence, Narcotic, Animal, Dog, NSF, Chemical substance

Canaery , the neurotech company revolutionizing the detection of important scents in real-world settings, today announced it has secured $650,000 in Phase 1 funding from the U.S. National Science Foundation (NSF) Convergence Accelerator leading an interdisciplinary team of scientists, engineers and operators.

Key Points: 
  • Canaery , the neurotech company revolutionizing the detection of important scents in real-world settings, today announced it has secured $650,000 in Phase 1 funding from the U.S. National Science Foundation (NSF) Convergence Accelerator leading an interdisciplinary team of scientists, engineers and operators.
  • Teams that successfully complete Phase 1 may qualify for up to $5 million in Phase 2 funding.
  • View the full release here: https://www.businesswire.com/news/home/20240213816441/en/
    The NSF Convergence Accelerator prioritizes projects with potential for positive societal and economic impact.
  • “For Phase 1 of the NSF Convergence Accelerator program we have assembled an expert team to demonstrate multiple simultaneous detections of critical odors in real world environments,” said Peter Ledochowitsch, PhD, CTO and co-founder, Canaery.

Innospec Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, February 13, 2024
Acquisition, Innospec, QGP, Growth, Chemical substance, GAAP, Depreciation, Optimism, Public expenditure, EPS, Corporation, Bank statement, Video game

Commenting on the fourth quarter results, Patrick S. Williams, President and Chief Executive Officer, said,

Key Points: 
  • Commenting on the fourth quarter results, Patrick S. Williams, President and Chief Executive Officer, said,
    “This was another very good quarter for Innospec.
  • Fuel Specialties achieved double-digit operating income growth in the quarter and gross margins were within our target range of 32 to 35 percent.
  • Revenues in Oilfield Services of $175.4 million for the quarter decreased 4 percent from the $183.5 million in the fourth quarter last year.
  • As of December 31, 2023, Innospec had net cash of $203.7 million compared to net cash of $147.1 million a year ago.

Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good practice

Retrieved on: 
Tuesday, February 13, 2024
VCI, AFPM, World Resources Institute, National Association, National Association of Manufacturers, WRI, Climate, Paris Agreement, LYB, Commerce, Communication, Carbon, Risk, CDP, Climate change, Chemical substance, NESN, LyondellBasell, NAM

Chemical giant LyondellBasell (LYB) has emerged as an example of better practice in this field by proactively addressing concerns over misaligned industry affiliations.

Key Points: 
  • Chemical giant LyondellBasell (LYB) has emerged as an example of better practice in this field by proactively addressing concerns over misaligned industry affiliations.
  • The company's Climate Advocacy Report , released in May 2023, evaluates its memberships in key trade associations, categorising each based on alignment with climate policy positions.
  • Another example of good practice is provided by Bayer’s (BAY) Industry Association Climate Review (2023) which assesses 63 associations.
  • As the world grapples with climate challenges, the time for blurred communication is long gone, and corporate leaders should be clear about their climate transition pathway.

Global Oxygen Sensor Market Outlook 2022-2035: Automotive and Healthcare Sectors to Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, February 5, 2024
Automotive Manufacturing, Manufacturing, Other Manufacturing, Machinery, Machine Tools, Metalworking & Metallurgy, Growth, Market value, Chemical substance, USD, Segment, Water, Medicine, Amperometry, Automotive industry

The global oxygen sensor market is projected to grow at a CAGR of 6.8% over the forecast period.

Key Points: 
  • The global oxygen sensor market is projected to grow at a CAGR of 6.8% over the forecast period.
  • This growth could be influenced by rising demand for automotive, along with rising use of oxygen sensor in healthcare sector.
  • The global oxygen sensor market is segmented into numerous segments which includes, segmentation by product type, technology, and by end user industry.
  • Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035
    Market Increment $ Opportunity Assessment, 2022-2035
    Global Oxygen Sensor Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035
    Potentiometric Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035
    Amperometric Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035
    Resistive Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035
    Infrared Market Value (USD Million) Current and Future Projections, 2022-2035
    Catalytic Market Value (USD Million) Current and Future Projections, 2022-2035
    Chemical and Petrochemical Market Value (USD Million) Current and Future Projections, 2022-2035
    Automotive Market Value (USD Million) Current and Future Projections, 2022-2035
    Medical and Life Sciences Market Value (USD Million) Current and Future Projections, 2022-2035
    Industrial Market Value (USD Million) Current and Future Projections, 2022-2035
    Water and Wastewater Market Value (USD Million) Current and Future Projections, 2022-2035
    Smart Buildings Market Value (USD Million) Current and Future Projections, 2022-2035
    North America Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035
    Europe Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035
    Asia Pacific Excluding Japan Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035
    Japan Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035
    Latin America Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035
    Middle East & Africa Market Value (USD Million), Volume (Thousand Units) Current and Future Projections, 2022-2035

Hawkins, Inc. Reports Third Quarter Fiscal 2024 Results

Retrieved on: 
Wednesday, January 31, 2024
EPS, Growth, Water treatment, Chemical substance, Tax, Interest, Water, Nutrition, Health, Acquisition, Depreciation, Sale, Video game

ROSEVILLE, Minn., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three and nine months ended December 31, 2023, its third quarter of fiscal 2024.

Key Points: 
  • ROSEVILLE, Minn., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three and nine months ended December 31, 2023, its third quarter of fiscal 2024.
  • Third Quarter Fiscal Year 2024 Highlights:
    Third quarter sales of $208.5 million, with Water Treatment segment sales growth of 20% over the same quarter in the prior year.
  • For the third quarter of fiscal 2024, the Company reported net income of $14.9 million, or $0.71 per diluted share, compared to net income for the third quarter of fiscal 2023 of $10.7 million, or $0.51 per diluted share.
  • Sales were $208.5 million for the third quarter of fiscal 2024, a decrease of $10.7 million, or 5%, from sales of $219.2 million in the same period a year ago.